Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting

The Epidemic of the 20th Century: Coronary Heart Disease

Anne B. Yates, MD The American Journal of Medicine

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Unusual Cause of Leg Ulcerations

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Chirag Bavishi, MD, MPH,

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

James H. Liu, MD The American Journal of Medicine

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Introduction The American Journal of Medicine

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials Kenneth R. McQuaid, MD, Loren.

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Athena Philis-Tsimikas, MD The American Journal of Medicine

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Wandering Acute Myocardial Infarction

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials Giulia Renda, MD, PhD, Marta.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,

The Epidemic of the 20th Century: Coronary Heart Disease

Carotid Sinus Massage in Patients with Suspected Acute Myocardial Infarction, Tachycardia, and Left Bundle Branch Block Teddy Weiss, MD, Yair Elitzur,

David D. McManus, MD, ScM, Wei Huang, MS, Kunal V

Parinaz K. Ghaswalla, PhD, Spencer E

Apurva O. Badheka, MD, Ankit Rathod, MD, Mohammad A

Methylene Chloride Intoxication Treated With Hyperbaric Oxygen Therapy

Michael A. Pfaller, MD The American Journal of Medicine

The Reply The American Journal of Medicine

TIA for the Internist The American Journal of Medicine

Gun Ownership and Firearm-related Deaths

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

Treatment of hepatitis C

Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis G. Caleb Alexander, MD, MS, Geetha Iyer, MBBS, Eleanor.

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

James H. O'Keefe, MD, Robert Vogel, MD, Carl J

Use of Serum c-Peptide Level to Simplify Diabetes Treatment Regimens in Older Adults Medha N. Munshi, MD, Mellody Hayes, BA, Adrianne Sternthal, Darlene.

When Guidelines Cause Hypertension

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Shelley R. Salpeter, MD, Peter Gregor, MD, Thomas M

The Reply The American Journal of Medicine

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

MATCH Results: Implications for the Internist

Insomnia in the Elderly: Cause, Approach, and Treatment

To Reduce Stroke with PFO Closure, Respect the Shunt

Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction Salman A. Haq, MD, John F. Heitner, MD, Terrence J.

Purple Urinary Bag Syndrome

A Post-cure Complication

Sister Mary Joseph's Node

The American Journal of Medicine

Laszlo Littmann, MD, PhD, Michael H. Monroe, MD

Direct Observation of Residents: A Model for an Assessment System

Falls in Older Adults: Risk Assessment, Management and Prevention

Invasive Mycoses: Diagnostic Challenges

Matthew W. Martinez, MD, Keith G. Rasmussen, MD, Paul S

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO, Joseph S. Alpert, MD The American Journal of Medicine Volume 127, Issue 7, Pages 579-585 (July 2014) DOI: 10.1016/j.amjmed.2014.02.030 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Cumulative risks for stroke with the 2 treatments (figure from the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events, reproduced with permission). RR = relative risk. The American Journal of Medicine 2014 127, 579-585DOI: (10.1016/j.amjmed.2014.02.030) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Complications during 12-month follow-up with various drug regimens adopted after stenting in warfarin group. Reproduced and modified with permission from the study by Karjalainen et al.4 MI = myocardial infarction. The American Journal of Medicine 2014 127, 579-585DOI: (10.1016/j.amjmed.2014.02.030) Copyright © 2014 Elsevier Inc. Terms and Conditions